Design
Review
Authors
Loading...
May guide ACE2-targeted therapies for hypertension and CKD; leaves open confirmation in randomized trials.
Key points are not available for this paper at this time.
Julie R. Ingelfinger (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: